Strategic objectives

• Advance in the understanding of cerebral ischemia pathology.
• Development of pharmacological strategies with therapeutic potential to improve functional recovery after ischemic stroke.
• Treatment of strokes in the acute phase.

Research lines
Lines of clinical research:

• Secondary prevention in stroke
• Reperfusion treatments in cerebral infarction. Use of neuroprotective drugs.
• Cerebrovascular complications in patients on antivitamin K therapy.
• Recurrent cardioembolic strokes. New indications for atrial appendage closure. Carotid filters. 
• Coagulation factor XI inhibitors in non-cardioembolic strokes.
• Analysis of thrombi removed by mechanical thrombectomy.

Lines of experimental research:

• Mechanisms of death and neuroprotection in cerebral ischemia.
• Identification of proteins involved in neurorepair after cerebral ischemia. Clinical experimental study.
• Exploration of new neuroprotective drugs for cerebral ischemia.
• Study of non-excitatory amino acid transporters as new molecular targets in brain damage caused by ischemia.